Efficacy and Safety Study of Cyclosporine 0.010% to Treat Atopic Keratoconjunctivitis

Clinical trial NCT00884585 · COMPLETED

Trial details

NCT number: NCT00884585
Sponsor: Allergan
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Atopic Conjunctivitis

Start date: 2009-05-01
Primary completion: 2010-10-01
Enrollment: 176

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.